WBR0516: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 22: | Line 22: | ||
|Prompt=A 32-year-old woman delivers a 38-week-old boy after a non-controlled pregnancy. She is known hypertensive, she was taking enalapril to control her blood pressure. She assisted to her first trimester control, when the physician told her that it was necessary to stop her medication because it was associated with many fetal problems. Regardless of the medical advice she continued taking enalapril. Upon delivery and physical examination, the newborn is suspected to have malformations and renal damage after the chronic in-utero exposure to this drug. Which of the following changes in an adult kidney physiology occurs with the use of enalapril? | |Prompt=A 32-year-old woman delivers a 38-week-old boy after a non-controlled pregnancy. She is known hypertensive, she was taking enalapril to control her blood pressure. She assisted to her first trimester control, when the physician told her that it was necessary to stop her medication because it was associated with many fetal problems. Regardless of the medical advice she continued taking enalapril. Upon delivery and physical examination, the newborn is suspected to have malformations and renal damage after the chronic in-utero exposure to this drug. Which of the following changes in an adult kidney physiology occurs with the use of enalapril? | ||
|Explanation=* [[Enalapril]] is an [[ACE]] (angiotensin converting enzyme) inhibitor medication used to treat [[hypertension]]. ACE inhibitors and aldosterone receptor blockers are associated with many fetal malformations if used during pregnancy (teratogenic), especially renal damage. | |Explanation=* [[Enalapril]] is an [[ACE]] (angiotensin converting enzyme) inhibitor medication used to treat [[hypertension]]. ACE inhibitors and aldosterone receptor blockers are associated with many fetal malformations if used during pregnancy (teratogenic), especially renal damage. | ||
* '''ACE inhibitors are associated with the following teratogenic effects:''' | * '''ACE inhibitors are associated with the following teratogenic effects:''' hypotension, renal dysplasia, anuria or oliguria, oligohydramios, intrauterine growth retardation (IUGR), pulmonary hypoplasia, patent ductus arteriosus (PDA), incomplete ossification of the skull, intrauterine neonatal death | ||
* '''Physiology:''' | * '''Physiology:''' normally [[angiotensin]] II (AT-II) constricts the glomerular efferent arteriole, which causes an increase in the hydrostatic pressure within the glomerulus increasing the glomerular filtration rate (GFR). AT-II by constricting the efferent arteriole, decreases the renal plasma flow (RPF). By decreasing RPF and increasing GFR, AT-II increases the filtration fraction (FF), which is GFR/RPF. | ||
* ACE inhibitors such as enalapril, decrease AT-II which cause the inverse effect, therefore by inhibiting the production of angiotensin II (AT-II), it decreases the FF by dilating the efferent arteriole. With enalapril the hydrostatic pressure within the glomerulus decreases, which decreases GFR. By decreasing the resistance in the efferent arteriole, the renal plasma flow increases, which ultimately leads to decrease in filtration fraction. ACE inhibitors are contraindicated in patients with renal artery stenosis, because the blood flow decreases even more and the filtration fraction decreases, therefore the patient is prone to develop renal insufficiency. | * ACE inhibitors such as enalapril, decrease AT-II which cause the inverse effect, therefore by inhibiting the production of angiotensin II (AT-II), it decreases the FF by dilating the efferent arteriole. With enalapril the hydrostatic pressure within the glomerulus decreases, which decreases GFR. By decreasing the resistance in the efferent arteriole, the renal plasma flow increases, which ultimately leads to decrease in filtration fraction. ACE inhibitors are contraindicated in patients with renal artery stenosis, because the blood flow decreases even more and the filtration fraction decreases, therefore the patient is prone to develop renal insufficiency. | ||
[[File:RAAS Phys.png|center|600px]] | [[File:RAAS Phys.png|center|600px]] | ||
Line 34: | Line 34: | ||
|AnswerA=Increase in FF, increase in GFR and decrease in RPF | |AnswerA=Increase in FF, increase in GFR and decrease in RPF | ||
|AnswerAExp=<font color="red">'''Incorrect.'''</font> Corresponds to the AT-II functions | |AnswerAExp=<font color="red">'''Incorrect.'''</font> Corresponds to the AT-II functions | ||
|AnswerB=Decrease FF, decrease GFR and increase RPF | |AnswerB=Decrease FF, decrease GFR and increase RPF | ||
|AnswerBExp=<font color="Green">'''Correct.'''</font> ACE inhibitor effect | |AnswerBExp=<font color="Green">'''Correct.'''</font> ACE inhibitor effect | ||
|AnswerC=No change in FF, decrease in GFR and decrease in RPF | |AnswerC=No change in FF, decrease in GFR and decrease in RPF | ||
|AnswerCExp=<font color="red">'''Incorrect.'''</font> Constriction of afferent arteriole | |AnswerCExp=<font color="red">'''Incorrect.'''</font> Constriction of afferent arteriole | ||
|AnswerD=Increase in FF, Increase in GFR and no change in RPF | |AnswerD=Increase in FF, Increase in GFR and no change in RPF | ||
|AnswerDExp=<font color="red">'''Incorrect.'''</font> Corresponds to hypoalbuminemia | |AnswerDExp=<font color="red">'''Incorrect.'''</font> Corresponds to hypoalbuminemia | ||
|AnswerE=Decrease in FF, decrease in GFR and no change RPF | |AnswerE=Decrease in FF, decrease in GFR and no change RPF | ||
|AnswerEExp=<font color="red">'''Incorrect.'''</font> Corresponds to hyperalbuminemia | |AnswerEExp=<font color="red">'''Incorrect.'''</font> Corresponds to hyperalbuminemia |
Revision as of 18:22, 25 September 2013
Author | [[PageAuthor::Gonzalo A. Romero, M.D. [1]]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Physiology |
Sub Category | SubCategory::Renal, SubCategory::Vascular |
Prompt | [[Prompt::A 32-year-old woman delivers a 38-week-old boy after a non-controlled pregnancy. She is known hypertensive, she was taking enalapril to control her blood pressure. She assisted to her first trimester control, when the physician told her that it was necessary to stop her medication because it was associated with many fetal problems. Regardless of the medical advice she continued taking enalapril. Upon delivery and physical examination, the newborn is suspected to have malformations and renal damage after the chronic in-utero exposure to this drug. Which of the following changes in an adult kidney physiology occurs with the use of enalapril?]] |
Answer A | AnswerA::Increase in FF, increase in GFR and decrease in RPF |
Answer A Explanation | [[AnswerAExp::Incorrect. Corresponds to the AT-II functions]] |
Answer B | AnswerB::Decrease FF, decrease GFR and increase RPF |
Answer B Explanation | [[AnswerBExp::Correct. ACE inhibitor effect]] |
Answer C | AnswerC::No change in FF, decrease in GFR and decrease in RPF |
Answer C Explanation | [[AnswerCExp::Incorrect. Constriction of afferent arteriole]] |
Answer D | AnswerD::Increase in FF, Increase in GFR and no change in RPF |
Answer D Explanation | [[AnswerDExp::Incorrect. Corresponds to hypoalbuminemia]] |
Answer E | AnswerE::Decrease in FF, decrease in GFR and no change RPF |
Answer E Explanation | [[AnswerEExp::Incorrect. Corresponds to hyperalbuminemia]] |
Right Answer | RightAnswer::B |
Explanation | [[Explanation::* Enalapril is an ACE (angiotensin converting enzyme) inhibitor medication used to treat hypertension. ACE inhibitors and aldosterone receptor blockers are associated with many fetal malformations if used during pregnancy (teratogenic), especially renal damage.
Educational Objective:
|
Approved | Approved::Yes |
Keyword | WBRKeyword::Filtration fraction, WBRKeyword::GFR, WBRKeyword::ACE inhibitor, WBRKeyword::enalapril |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |